Form 4 Tracker
Todd Watanabe

Director, Reporting Person's title: President and Chief Executive Officer · 3 filings · Latest: May 4, 2026

Arcutis Biotherapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ARQT
Todd WatanabeDirector, Reporting Person's title: President and Chief Executive OfficerMay 4, 2026
Sale
$23.613,172$74.9K720,755
ARQT
Todd WatanabeMay 4, 2026
Proposed Sale
$23.613,172$74.9K
ARQT
Todd WatanabeDirector, Reporting Person's title: President and Chief Executive OfficerMar 2, 2026
Sale
$25.1837,349$940.5K785,957
ARQT
Todd WatanabeMar 2, 2026
Proposed Sale
$25.1837,349$940.5K
ARQT
Todd WatanabeDirector, Reporting Person's title: President and Chief Executive OfficerFeb 2, 2026
Sale
$25.5019,833$505.7K721,306
ARQT
Todd Frank WatanabeFeb 2, 2026
Proposed Sale
$25.5019,833$505.7K
ARQT
Todd Franklin WatanabeNov 24, 2025
Proposed Sale
$30.3648,945$1.5M
ARQT
Todd Franklin WatanabeNov 21, 2025
Proposed Sale
$30.001,055$31.6K
ARQT
Todd Franklin WatanabeNov 3, 2025
Proposed Sale
$24.7211,547$285.4K
ARQT
Todd F watanabeOct 28, 2025
Proposed Sale
$25.0340,000$1.0M
ARQT
Todd Franklin WatanabeOct 2, 2025
Proposed Sale
$20.0420,739$415.6K
ARQT
Todd Franklin WatanabeOct 1, 2025
Proposed Sale
$19.3324,261$469.1K
ARQT
Watanabe ToddSep 9, 2025
Proposed Sale
$17.52504$8.8K
ARQT
Watanabe ToddSep 8, 2025
Proposed Sale
$17.549,625$168.8K
ARQT
Watanabe ToddAug 4, 2025
Proposed Sale
$14.3311,547$165.4K
ARQT
Watanabe Todd FranklinMay 2, 2025
Proposed Sale
$15.1911,448$173.9K
ARQT
Watanabe Todd FranklinMar 25, 2025
Proposed Sale
$17.562,171$38.1K
ARQT
Watanabe Todd FranklinMar 24, 2025
Proposed Sale
$17.521,500$26.3K
ARQT
Watanabe Todd FranklinMar 17, 2025
Proposed Sale
$17.611,200$21.1K
ARQT
Watanabe Todd FranklinMar 4, 2025
Proposed Sale
$13.284,135$54.9K

Page 1 of 2

Next →

Todd Watanabe — Insider Trading Activity | LevelFields AI